SPDR S&P Biotech ETF (NYSEARCA:XBI) Stock Position Reduced by Modera Wealth Management LLC

Modera Wealth Management LLC lessened its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 7.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 21,766 shares of the exchange traded fund’s stock after selling 1,723 shares during the quarter. Modera Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $1,960,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Howard Capital Management Group LLC raised its stake in shares of SPDR S&P Biotech ETF by 2.6% during the 3rd quarter. Howard Capital Management Group LLC now owns 248,114 shares of the exchange traded fund’s stock worth $24,514,000 after purchasing an additional 6,188 shares in the last quarter. Focus Financial Network Inc. acquired a new stake in SPDR S&P Biotech ETF in the third quarter valued at approximately $218,000. Quintet Private Bank Europe S.A. bought a new stake in SPDR S&P Biotech ETF in the third quarter worth approximately $40,000. Graypoint LLC increased its stake in shares of SPDR S&P Biotech ETF by 5.6% during the 3rd quarter. Graypoint LLC now owns 2,738 shares of the exchange traded fund’s stock worth $271,000 after purchasing an additional 146 shares during the last quarter. Finally, Advisor Resource Council bought a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at $260,000.

SPDR S&P Biotech ETF Trading Down 3.5 %

Shares of NYSEARCA:XBI opened at $85.60 on Tuesday. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The firm has a fifty day moving average price of $90.88 and a 200 day moving average price of $95.66. The stock has a market capitalization of $5.65 billion, a PE ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.